INNOVATION PHARMACEUTICALS INC. Current Liabilities
INNOVATION PHARMACEUTICALS INC. had Current Liabilities of $5.05 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2023-11-20
- 2023-09-30: Liabilities, Current $5.05M.
- 2023-06-30: Liabilities, Current $5.02M.
- 2023-03-31: Liabilities, Current $4.82M.
- 2022-12-31: Liabilities, Current $4.82M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2023-09-30 | $5.05M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $5.02M 10-Q · filed 2023-11-20 | |
| 2023-03-31 | $4.82M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $4.82M 10-Q · filed 2023-02-15 | |
| 2022-09-30 | $5.13M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $4.81M 10-K · filed 2023-09-28 | |
| 2022-03-31 | $4.59M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $4.49M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $6.23M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $6.54M 10-K · filed 2022-09-28 | |
| 2021-03-31 | $6.42M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $6.80M 10-Q · filed 2021-02-22 | |
| 2020-09-30 | $6.64M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $7.37M 10-K · filed 2021-09-27 | |
| 2020-03-31 | $7.83M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $7.81M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $7.47M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $7.30M 10-K · filed 2020-09-14 | |
| 2019-03-31 | $7.59M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $7.96M 10-Q · filed 2019-02-08 | |
| 2018-09-30 | $8.28M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $8.69M 10-K · filed 2019-09-30 | |
| 2018-03-31 | $9.47M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $10.62M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $10.83M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $10.58M 10-K · filed 2018-09-11 | |
| 2017-03-31 | $9.33M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $8.66M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $8.77M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $8.48M 10-K · filed 2017-09-11 | |
| 2016-03-31 | $8.43M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $7.64M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $7.48M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $7.29M 10-K · filed 2016-09-13 | |
| 2015-03-31 | $7.31M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $7.74M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $7.97M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $9.65M 10-K · filed 2015-09-11 | |
| 2014-03-31 | $9.39M 10-Q/A · filed 2014-05-16 | |
| 2013-12-31 | $9.33M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $9.41M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $8.14M 10-K · filed 2014-09-15 | $8.14M 10-K · filed 2013-09-30 |
| 2013-03-31 | $8.16M 10-Q · filed 2013-05-20 | |
| 2012-12-31 | $7.92M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $7.53M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $7.38M 10-K · filed 2013-09-30 | |
| 2012-03-31 | $7.16M 10-Q · filed 2012-05-18 | |
| 2011-12-31 | $8.48M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $6.78M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $6.77M 10-K · filed 2012-10-12 |